Literature DB >> 26471936

Targeting astrocytes in major depression.

Liang Peng1, Alexei Verkhratsky, Li Gu1, Baoman Li1.   

Abstract

Astrocytes represent a highly heterogeneous population of neural cells primarily responsible for the homeostasis of the CNS. Astrocytes express multiple receptors for neurotransmitters, including the serotonin 5-HT2B receptors and interact with neurones at the synapse. Astroglia contribute to neurological diseases through homeostatic response, neuroprotection and reactivity. In major depression, astrocytes show signs of degeneration and are decreased in numbers, which may lead to a misbalance in neurotransmission and aberrant synaptic connectivity. In this review, we summarize astroglia-specific effects of major antidepressants and outline future strategies for astroglia-specific therapy in neuropsychiatric disorders.

Entities:  

Keywords:  astrocytes; major depression; mechanism of drug action; neuropsychiatric diseases; serotonin-specific reuptake inhibitors

Mesh:

Substances:

Year:  2015        PMID: 26471936     DOI: 10.1586/14737175.2015.1095094

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  16 in total

Review 1.  The homeostatic astroglia emerges from evolutionary specialization of neural cells.

Authors:  Alexei Verkhratsky; Maiken Nedergaard
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-08-05       Impact factor: 6.237

Review 2.  Physiology of Astroglia.

Authors:  Alexei Verkhratsky; Maiken Nedergaard
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

3.  Mechanism of depression as a risk factor in the development of Alzheimer's disease: the function of AQP4 and the glymphatic system.

Authors:  Maosheng Xia; Li Yang; Guangfeng Sun; Shuang Qi; Baoman Li
Journal:  Psychopharmacology (Berl)       Date:  2016-11-12       Impact factor: 4.530

4.  Astroglial Serotonin Receptors as the Central Target of Classic Antidepressants.

Authors:  Alexei Verkhratsky; Vladimir Parpura; Caterina Scuderi; Baoman Li
Journal:  Adv Neurobiol       Date:  2021

Review 5.  Blood-Brain Barrier Dysfunction in the Pathogenesis of Major Depressive Disorder.

Authors:  Shusheng Wu; Yuye Yin; Longfei Du
Journal:  Cell Mol Neurobiol       Date:  2021-10-12       Impact factor: 4.231

6.  Modulatory Effects of Antidepressant Classes on the Innate and Adaptive Immune System in Depression.

Authors:  H A Eyre; H Lavretsky; J Kartika; A Qassim; B T Baune
Journal:  Pharmacopsychiatry       Date:  2016-03-07       Impact factor: 5.788

Review 7.  Neuroimmune signaling in alcohol use disorder.

Authors:  Emma K Erickson; Emily K Grantham; Anna S Warden; R A Harris
Journal:  Pharmacol Biochem Behav       Date:  2018-12-24       Impact factor: 3.533

8.  The Association Between Antidepressant Effect of SSRIs and Astrocytes: Conceptual Overview and Meta-analysis of the Literature.

Authors:  Beina Chen; Manman Zhang; Ming Ji; Wenliang Gong; Binjie Chen; Robert Zorec; Matjaž Stenovec; Alexei Verkhratsky; Baoman Li
Journal:  Neurochem Res       Date:  2021-02-01       Impact factor: 3.996

9.  Profiling changes in cortical astroglial cells following chronic stress.

Authors:  Stephanie Simard; Gianfilippo Coppola; Christopher A Rudyk; Shawn Hayley; Robyn J McQuaid; Natalina Salmaso
Journal:  Neuropsychopharmacology       Date:  2018-05-29       Impact factor: 7.853

Review 10.  Depression as a Glial-Based Synaptic Dysfunction.

Authors:  Daniel Rial; Cristina Lemos; Helena Pinheiro; Joana M Duarte; Francisco Q Gonçalves; Joana I Real; Rui D Prediger; Nélio Gonçalves; Catarina A Gomes; Paula M Canas; Paula Agostinho; Rodrigo A Cunha
Journal:  Front Cell Neurosci       Date:  2016-01-22       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.